Clinical Trials and Research Studies

At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.

Recently Added/Updated Trials

  • A single-center observational longitudinal study to monitor skeletal muscle aging with quantitative MRI

    A single-center observational longitudinal study to monitor skeletal muscle aging with quantitative MRI

    View Details

  • A SINGLE-CENTER OBSERVATIONAL STUDY OF CLINICAL OUTCOMES FOLLOWING TREATMENT OF LEIOMYOMA WITH COMBINATION THERAPY UTILIZING GNRH ANALOGS AND TRANSCERVICAL FIBROID ABLATION

    A SINGLE-CENTER OBSERVATIONAL STUDY OF CLINICAL OUTCOMES FOLLOWING TREATMENT OF LEIOMYOMA WITH COMBINATION THERAPY UTILIZING GNRH ANALOGS AND TRANSCERVICAL FIBROID ABLATION

    View Details

  • Microbial and Host Biomarkers for Endotyping Venous Thromboembolism Patients

    Microbial and Host Biomarkers for Endotyping Venous Thromboembolism Patients

    View Details

  • Time to Union: A Comparison of the Medartis Scaphoid Volar Locking Plate and Headless Compression Screws for Treatment of Scaphoid Nonunion

    Time to Union: A Comparison of the Medartis Scaphoid Volar Locking Plate and Headless Compression Screws for Treatment of Scaphoid Nonunion

    View Details

  • A SINGLE-CENTER OBSERVATIONAL STUDY OF PAIN PHENOTYPES IN PSORIATIC ARTHRITIS

    A SINGLE-CENTER OBSERVATIONAL STUDY OF PAIN PHENOTYPES IN PSORIATIC ARTHRITIS

    View Details

  • The (IRAD) International Registry for Acute Aortic Dissection

    The (IRAD) International Registry for Acute Aortic Dissection

    View Details

  • A Phase 2 Open Label Study of REC-4881 in Participants with Unresectable Locally Advanced or Metastatic Cancer with AXIN1 or APC Mutation

    A Phase 2, Open Label Study of REC-4881 in Participants with Unresectable Locally Advanced or Metastatic Cancer with AXIN1 or APC Mutation

    View Details

  • MAGNITUDE: A Phase 3 Multinational Multicenter Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)

    MAGNITUDE: A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy ...

    View Details